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1. Introduction 
More than 42 million people around the world are currently infected with the Human 
Immunodeficiency Virus (HIV), which causes the Acquired Immunodeficiency Syndrome 
(AIDS) (Ojukwu, 2004). Although new cases of HIV/AIDS infections have declined in most 
developed countries, the virus has spread rapidly through much of the developing world. In 
some areas of sub-Saharan Africa, one in four adults is infected with the virus (Saloner, 
2002). Acquired Immunodeficiency Syndrome (AIDS) comprises a collection of symptoms 
and infections, which result from specific damage to the immune system as a result of HIV. 
Latter stages of the condition leave individuals susceptible to opportunistic infections and 
tumours (Arnett 2001; UNAIDS, 2004).  
Most European researchers believe that HIV originated from sub-Saharan Africa. Although 
this allegation may appear to be libellous, sub-Saharan Africa has become one of the worst 
affected regions (UNAIDS, 2003). An estimated 38.6 million people currently live with the 
disease worldwide (Nunn, Baggaley, Melby & Thomas, 2004). According to the joint United 
Nations Program on HIV/AIDS (UNAIDS, 2006), HIV/AIDS has killed more than 25 
million people since it was first recognized in 1981, which makes it one of the most 
destructive epidemics in recorded history. HIV/AIDS has claimed an estimated 2.4-3.3 
million lives, of which more than 570,000 were children in 2005 (WHO, 2006). Almost one 
third of the deaths accruing to HIV/AIDS, occurred in sub-Saharan Africa. This 
development has adversely impacted on economic growth and human capital development 
within this region.  
Antiretroviral treatment reduces both mortality and morbidity regarding HIV infection, 
however, routine access to antiretroviral medication is not available in all countries (WHO, 
2003). HIV/AIDS stigma is more severe than that associated with other life-threatening 
conditions and extends beyond affected individuals, care providers and even volunteers 
who are involved with caring for people who live with the disease (Salati, 2004). 
Evidently, the physical size of a country, its population and its national income level per 
head, are important determinants of economic potential- a major factor, which differentiates 
one country from another. A country’s potential for economic growth is influenced by its 
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endowment of physical resources (land, minerals and raw materials), in addition to its 
endowment of human resources (the number of people in a country and their skill level) 
(Dhar, 1995). However, the latter seems to have been demoted by the scourge of the 
HIV/AIDS pandemic within regions that are most affected. That HIV/AIDS epidemic has 
been ravishing the world for the past three decades, is a given fact and, therefore, calls for 
urgent action both individually and collectively. This paper attempts to ascertain the 
possibility of a relationship between HIV/AIDS and productivity of worst affected regions 
pursuant to broadening knowledge regarding HIV/AIDs as it affects the global economy. 
The following hypothesis is proposed: 
• HO1: there is no significant relationship between the productivity of a total population 
and the productivity of a reduced population owing to the HIV/AIDS epidemic. 
• HA1: there is a significant relationship between the productivity of total a population 
and the productivity of a reduced population owing to the HIV/AIDS epidemic.  
2. Diagnoses of HIV/AIDS 
Since its inception, several definitions have been developed for epidemiological surveillance 
such as the Bangui definition and the 1994 expanded World Health Organization AIDS case 
definition. However, clinical staging of patients was not an intended use for these systems 
as they are neither sensitive nor specific. In developing countries, the World Health 
Organization’s staging system for HIV infection and disease relied on clinical and laboratory 
data (UNAIDS, 2004). In 1990, the World Health Organization (WHO) grouped these 
infections and conditions by introducing a staging for patients infected with HIV-1, which 
was updated in September 2005 (WHO 2006). Most of these conditions are opportunistic 
infections that are easily treatable in healthy people. 
i. Stage i: HIV infection is asymptomatic and not categorized as AIDS. 
ii. Stage ii: includes minor mucocutaneous manifestations and recurrent upper respiratory 
tract infections. 
iii. Stage iii: includes unexplained chronic diaorrhea for longer than a month, severe 
bacterial infections and pulmonary tuberculosis. 
iv. Stage iv: includes toxoplasmosis of the brain, candidacies of the esophagus, trachea, 
broneli or lungs and Kaposi’s Sarcoma, which are all diseases that are indicative of 
AIDS. 
Previously, the Centre for Disease Control and Prevention (CDCP) did not have an official 
name for the disease, and had often referred to it by other diseases that were associated with 
it, for example, lymphadenopathy, a disease after which the discoverers of HIV originally 
named the virus. They also used Kaposi Sarcoma, an opportunistic infection, and named a 
task force after this, which was set up in 1981. In the general press, the term GRID, which 
abbreviated Gay-Related Immune Deficiency, was also coined (Goldstein, 1983). However, 
after determining that AIDS was not confined to the homosexual community, the term 
GRID became misleading, therefore, AIDS was adopted at a meeting in July 1982 (Altman, 
1984). By September 1982, the CDCP began to use the name AIDS to include all HIV positive 
people with a CD4+T cell count below 200 per µl of blood. However, 14% of all cases in 
developed countries use either this definition or the pre-1993 CDCP definition.  
AIDS diagnosis still applies even if, after treatment, the CD4+T cell count rises to above 200 
per µl of blood, and even if other AIDS-defining illnesses are cured (Black, 1986, Nomcebo, 
2005). The following criteria should be satisfied before a diagnosis of AIDS can be made: 
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First and foremost, there should be laboratory evidence of infection with the HIV, which is 
usually achieved by demonstrating the presence of antibodies, to the virus. In the absence of 
antibodies a diagnosis may be made by viral isolation or viral antigen detection by means of 
serological tests (International AIDS Society, 2000). If possible, laboratory evidence of 
deficient cell mediated immunity should be demonstrated. The following tests should be 
conducted: total lymphocyte count, T cell subset, delayed hypersensitivity skin testing by 
using a number of antigens and lymphocyte proliferative studies, which uses various 
mitogens (Daka & Loha, 2008). In addition, there should be clinical evidence, which is either 
definitive or presumptive of opportunistic infections, certain cancers or direct central 
nervous system involvement owing to virus infection of the brain (AVERT, 2009). 
3. Pathophysiology  
Retroviruses have a unique method of reproducing, which allows the virus to copy its 
genetic information into a form that can be integrated into the host cells’ own genetic code. 
Each time the host cell divides, viral copies are produced along with more host cells. The 
HIV attacks and gradually depletes a specialized group of lymphocytes, T helper or T4 cells. 
T cells normally play a key role in setting the immune system’s responses in motion 
(McMichael, 2000). They send out chemical signals that stimulate production of antibodies 
and trigger maturation of other types of cells within the immune systems (B cell, 
macrophages and nerve cells). HIV not only depletes T helper cells, but also prevents 
remaining cells from functioning properly. B-cells become defective in an ability to produce 
immunoglobulin in response to appropriate stimuli. Loss of immunity is selective and 
affects primarily parts of the immune system that are involved in defenses against parasites, 
viral and fungal organisms, hence people who have AIDS, develop certain unusual life 
infections (ibid). 
 
Diagrammatic illustration of stages of HIV 
Infection 
↓ 
Development of antibodies (seroconversion) 
 
↓ 
Asymptomatic carrier state 
↓ 
AIDS related complex 
(Non-life threatening conditions) 
 
↓ 
Continuing asymptomatic state -------- recovery ------ continuing illness 
 
↓ 
AIDS and other life threatening conditions 
 
↓ 
Death 
Source: Ukpere, 2007. 
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Several common diseases such as tuberculosis, malaria, influenza, measles malnutrition and 
stress temporarily suppress immune response, but once infection subside immune system 
returns to normal but in AIDS it does not. Antibodies to HIV form in 1 – 4 months after 
infection but symptoms may not appear for up to 5 years and beyond in some cases and 
during these years, a person can transmit the virus to others without knowing. 
4. Prevention 
Perhaps the most important fact about AIDS is that it is a preventable disease. Ideally, this 
can be achieved by development of a vaccine, although much effort and money have been 
directed towards production of a vaccine. However, presently, there is none yet, and, it is 
unlikely that one will be available within the next five years (National Institute of Allergy 
and Infections Diseases (NIAID) 2009). In the absence of a vaccine, health education and 
counselling to create a sense of awareness and to reduce the risk of transmission by 
employing safe sex practices and other high risk behaviours, should become imperative 
(Centers for Disease Control & Prevention (CDCP), 2002). Other factors that may prevent 
the spread of AIDS includes ensuring a supply of safe blood and blood products, no sharing 
of needles and syringes and deferment of pregnancy among high risk subjects. Surveillance 
to monitor the size of the problem and how it changes, is an important component of 
prevention (ibid). 
4.1 HIV test 
In most developing countries, many people are not aware of their HIV status. Less than 1% 
of sexually active persons in urban Nigeria have been tested for HIV and this proportion is 
even lower within rural populations (Akande, 2001). Furthermore, a mere 0.5% of pregnant 
women who attend urban health facilities are counselled, tested or receive their test results. 
In fact, this proportion is even lower in rural health facilities. Hence, donor blood and blood 
products that are used in medicine and medical research, are screened for HIV (Nunn, et al., 
2004). A typical HIV test, including the HIV Enzyme Immunoassay (EI) and the Western 
Blot Assay (WBA), detects HIV antibodies in serum, plasma, oral fluid, dried blood spot and 
urine of patients. However, the window period (the time between initial infection and the 
development of detectable antibodies against the infection), can vary. This is why it can take 
3-6 months to seroconvert, test and detect other HIV antigens, HIV-RNA, and HIV-DNA 
(Scripps Research Institute, n.d). In order to detect HIV infection these assays are not 
officially approved, but are nonetheless routinely used in some countries. 
4.2 Transmission  
Three main transmission routes of HIV include sexual contact, exposure to infected body 
fluids or tissues and from mother to child during the prenatal period. It is possible to find 
HIV in the saliva, tears and urine of individuals but there have not been recorded cases of 
infection from these secretions (WHO, 2006). Therefore, the risk of infection through saliva, 
tears and urine is negligible. 
4.3 Sexual contact  
A majority of HIV infections are acquired through unprotected sexual contact between 
partners, one of whom has HIV (UNAID, 2004; Ojukwu, 2004). Sexual intercourse is a 
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primary mode of HIV infection worldwide. Sexual transmission occurs with contact 
between sexual secretions from one partner with the rectal, genital or oral mucous 
membranes of another. Unprotected receptive sexual acts have a greater risk of transmitting 
HIV from an infected partner to an uninfected partner through unprotected anal and 
vaginal intercourse/sex (Nomcebo, 2005). Oral sex is not without its risks as HIV may be 
transmissible through both assertive and receptive oral sex (HIV InSite, 2003). The WHO 
(2006) reported that the risk of HIV transmission from exposure to saliva is considerably 
smaller than the risk from exposure to semen. Contrary to popular belief, one would have to 
swallow gallons of saliva, for a person to run a significant risk of becoming infected. About 
30% of women in ten countries representing ‘diverse cultural, geographical and urban/ 
rural settings’, reported that their first sexual experiences were either forced or coerced, 
which makes sexual violence a key driver of the HIV/AIDS pandemic. Frequent sexual 
assaults result in physical trauma to the vaginal cavity, which facilitates transmission of 
HIV. During a sexual act, male/female condoms can reduce the chances of infection with 
HIV and other STDs, and of course the chances of becoming pregnant (Rutter & Quine, 2002; 
Nomcebo, 2005). The best evidence, to date, indicates that proper condom use reduces the 
risk of heterosexual HIV transmission by about 80% over the long-term. The benefit is 
higher if condoms are used correctly on every occasion. Promoting condom use, however, 
has often proven controversial and difficult. Several religious groups, particularly the 
Roman Catholic Church, have opposed the use of condoms on religious grounds and have 
sometimes perceived condom promotion as an affront to the promotion of marriage, 
monogamy and sexual morality (BBC News, 2009). 
5. Treatment  
WHO (2004) reported that there is currently no vaccine or cure for HIV/AIDS. The only 
known methods of prevention are based on avoiding exposure to the virus and an 
antiretroviral treatment, which, when taken directly after a highly significant exposure, 
called post-exposure prophylaxis (PEP), has a demanding four week schedule of dosage. 
Current treatments for HIV infection consist of highly active antiretroviral therapy 
(HAART). This has been highly beneficial to several HIV-infected individuals since its 
introduction in 1996 (UNAIDS, 2009). 
In the first decade of the epidemic when no useful conventional treatment was available, a 
large number of people who have AIDS experimented with alternative therapies (Nomcebo, 
2005). The definition of “alternative therapies” in AIDS has changed since then. During that 
time, the phrase often referred to community-driven treatments, were untested by 
government or pharmaceutical company research, and which most people hoped would 
directly suppress the virus or stimulate immunity against it. Despite widespread use of 
complementary and alternative medicines by people who live with HIV/AIDS, effectiveness 
of these therapies has not been established (UNAIDS, 2004). 
Treatment of AIDS consists of treatment of the HIV infection and complications, which 
result from the immune deficiency. A number of chemotherapeutic agents such as 
Zidovudine or AZT, Ribavirin, Suramin, Foscarnet and HPA- 23 have been used as antiviral 
agents, with limited success. Thus far, only Zidovudine has been approved for use in several 
countries, since it has been shown to cross the blood brain barrier. However, it is expensive 
and toxic to bone marrow. 
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5.1 Economic impact  
HIV/AIDS retards economic growth by destroying human capital. According to a UN 
report, HIV/AIDS epidemics will have devastating consequences in decades to come for 
virtually every sector of society ranging from households, farms and other economic 
activities (Nomcebo, 2005). The epidemic is predicted to hinder possibility of achieving UN 
millennium development goals within most affected regions, particularly sub Saharan 
Africa (Todaro, 1992). 
5.2 Impact on agriculture  
Agriculture is one of the most important sectors in several developing countries, 
particularly when measured by the percentage of people dependent on it for their 
livelihood. Although the sector may produce only 20% of a country’s wealth (measured as a 
percentage of the gross national product), it might provide a living (survival) for as much as 
80% of some developing countries’ populations (Agarwal, 2002). Indirectly, it provides a 
living for other parts of the population, for example, processing workers on sugar estates. 
The effect of AIDS is debilitating at a family level. As an infected farmer becomes 
increasingly ill, he and family members who take care of him, spend less and less time 
working on family crops. The family, therefore, begins to lose income from “un-marketed” 
or incompletely tended crops, and may even sell off farm implements or household 
properties as a means to survive (Dhar, 1999). 
This cycle is compounded by high costs of health care. Whether the sick person turns to a 
traditional healer or to health services, he/she will surely spend money. A 1997 study by the 
Food and Agriculture Organization of the United Nations (FAO) showed that in the mid-
west of Cote d’ ivories (Ivory Coast), care for male AIDS patients cost, on average, about 
US$ 300 a year, which is a quarter to a half of the net annual income for most small scale 
farms (Kaplan, 2000). The time lost by family members should also be taken into account. 
For instance, repeated absence of another member of the farm to accompany the patient to a 
healer, also reduces the farm’s production. Also, when the most debilitating phases of AIDS 
coincide with key farming periods such as clearing or sowing, time spent nursing a sick 
member, certainly has a negative impact on turnover (Answers.com, 2009). 
5.3 HIV and business 
Some companies in Africa have already felt the impact of HIV on their bottom line. A 
manager at one sugar processing estate in Kenya counted the cost of HIV infection in a 
number of ways: absenteeism (8000 days of labour cost owing to sickness between 1995 and 
1997 alone); lower productivity (50% drop in the ratio of processed sugar recovered from 
raw care between 1993 and 1997) and higher overtime costs for workers who are obliged to 
work longer hours to compensate for the void left by sick colleagues (Booth, 2005). 
6. Research methodology  
The research methodology encompasses different techniques and procedures that are used 
to collect and analyze data for research. This is important, since it provides a better view of 
how the conclusion was made. The methodology covers the population of study, method of 
data collection and data analysis technique.  
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6.1 Population of study  
The population of study comprises countries that have the highest prevalence of HIV/AIDS 
epidemic in sub-Saharan Africa. These countries are Botswana, Kenya, Uganda, South 
Africa and Zimbabwe, and were used to reflect rising trends of the epidemic.  
6.2 Method of data collection and analysis 
Data for the research was obtained from secondary sources such as textbooks, journal 
articles and the internet. The data collected was analyzed by use of the T-test, which is used 
when comparing two population means. The formula for finding significant differences 
between two independent means is stated as follows: 
 
( )( )
( ) ( )
1 2
2 2
1 2 2 1 2
1 2 1 2
t x x
Ns N S N N
N N 2 N N
= −
+ +
+ −
 
Where 1x = mean of the first group 
2x  = means of the second group  
N1 = number of cases in the first group 
N2 =number of cases in the second group 
S1 =standard deviation of the first group 
S2 =standard deviation of the second group 
In using this formula, the degree of freedom (d.f) is noted. 
At the end, if the value of the critical value is less than the calculated value, the null 
hypothesis is rejected and the alternative hypothesis is accepted. 
6.3 Data presentation and analysis 
The essence of this presentation and analysis is to ensure that the collected data is 
meaningful for decision-making. Therefore, this section is the critical aspect of the research, 
which provides the background upon which the results and conclusion of the study will 
rest. 
 
Countries 
Total Population  
 (in 000) 
Population with HIV/AIDS 
 (in 000) 
Population without 
HIV/AIDS (in 000) 
Botswana 
Kenya 
Zimbabwe 
South Africa 
Uganda 
Total 
1600 
34000 
12900 
44900 
27800 
12100 
300 
2300 
2000 
4700 
510 
9810 
1300 
31700 
10900 
40200 
27290 
111390 
Source: Field survey data, 2007. 
Table 1.1 Countries that have the highest prevalence of HIV/AIDS 
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An assumption is proposed that the productivity of these countries is one dollar ($1), in 
order to show manageable figures. The total population’s productivity is then compared 
with the productivity of the reduced population as a result of the influence of the epidemic. 
Finally, this is used to represent its effects on the world economy. 
 
 
 
 
Country Productivity of total
population  
 (in 000) 
Deviation  Productivity of population 
without HIV/AIDS 
Deviation 
Botswana  1,600 22640 1,300 22,940 
Kenya  34,000 9,760 31,700 7,460 
Zimbabwe  12,900 11,340 10,900 13,340 
South 
Africa  
44,900 20,660 40,200 15,960 
Uganda  27,800 3,560 27,290 3,050 
 n 
p=121,200 
101 
x1= 24,40 
n 
dx1=67,960 
I=i 
dR1=13,592 
nx1 
PW=111390 
I=i 
X2=22,278 
n=i 
dX2=62,750 
I=i 
dX2=12,550 
 
 
Table 1.2 Deviation of population with HIV/AIDS productivity and population productivity 
without HIV/AIDS  
Standard deviation 1
x 13,592
116.58
=
=
 
 Standard deviation 2
x 12,500
111.80
=
=
 
 
( )
( )
( )
( )
1 2
2 1 2
1 2 1 2
T test x x
N1s12 N S22 N N
N N 2 N xN
− = −
+ +
+ −
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Where, X1 is mean of the total population’s productivity=24,240 
X2 is mean of the reduced population’s productivity=22,278 
N1 is number of countries in the first group =5 
N2 is the same = 5 
S1= standard deviation of productivity of the total population =116.58 
S2 = standard deviation of the productivity of the reduced= 111.80 
 
( ) ( )( )
( )
( )
( )( )
( ) ( )( )
( )
( ) ( )
( ) ( )
2 2
t 24,240 22,278
5 116.58 5 118.80 5 5
5 5 2 5 5
1962
5 13,590.90 5 12,499.29
8
1962
67,9546 62,496.2
0.4
8
1962
16,306.34 0.4
1962
6522.535
1962
80.76
24.29
= −
+ +
+ −
=
+
=
+
=
=
=
=
 
 
Using the degree of freedom: N1 + N2-2 = 5+5-2=8 
Therefore, at a level of significance of 0.05, it could be observed that t – critical value is 
15.507. 
6.4 Decision 
Since the calculated value (24.29) > t- critical value (15.507), the null hypothesis is rejected 
and its alternative is accepted. This implies that there exists a significant relationship 
between the HIV/AIDS epidemic and productivity of the analysed region. 
7. Result and conclusion  
From the above analysis, it should be noted that the influence of the HIV/AIDS epidemic on 
general productivity, cannot be underrated. This could be judged from its influence on the 
productivity of countries that are most affected by the disease. Some empirical researches 
have correlated the life expectancies of these countries with their respective GDPs. 
Therefore, this paper has validated that there is a functional relationship between 
HIV/AIDS pandemic and a decrease in the productivity of selected affected Sub Saharan 
African regions. 
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not in any way limited to, care-seeking behaviour, adherence, access, psychosocial needs and support
services, discrimination and the impact the epidemic has on various sectors of the economy. The book has
seventeen chapters; seven chapters deal with social aspects of HIV/AIDS, four with psychosocial aspects of
HIV/AIDS, and the remaining six chapters with the impact of social and psychosocial factors on HIV/AIDS and
related behaviours. The book is an essential reading for academics, students and other people interested in
the field of HIV and AIDS.
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